Skewed X-chromosomal inactivation impacts T regulatory cell function in systemic sclerosis

  • JCA Broen
  • ILM Wolvers-Tettero
  • L Geurts-van Bon
  • M C Vonk
  • MJH Coenen
  • R Lafyatis
  • TRDJ Radstake
  • A W Langerak
Open Access
Oral presentation
  • 668 Downloads

Keywords

Androgen Receptor Systemic Sclerosis Foxp3 Expression Plasmacytoid Dendritic Cell Chromosomal Inactivation 

Aim

To investigate the role of X chromosomal inactivation (XCI) in systemic sclerosis (SSc) and its effects on forkhead box P3 (Foxp3) expression in T regulatory cells (Tregs).

Patients and methods

217 women with SSc and 107 healthy women (controls) were included in the study. From these subjects, DNA was isolated from total peripheral blood mononuclear cells, plasmacytoid dendritic cells, T cells, B cells, myeloid dendritic cells and monocytes after magnetic bead separation. All samples were assessed for skewed XCI patterns with the Human Androgen Receptor Assay. The outcome was assessed by linear regression. CD4+CD25+ cells were then isolated and intracellular Foxp3 expression was assessed by flow cytometry.

Results

Skewing was not associated with increased age in patients with SSc, in contrast to the control population (r=0.45, p<0.0001). Taking this into account, a significantly higher frequency of skewed XCI was found in patients with SSc compared with controls (p=0.001). No difference in skewing was observed between the immune cell subsets. In addition, a higher concentration of Foxp3+ cells exhibiting a lower Foxp3 mean fluorescence intensity was found in the patients with SSc, with profound XCI skewing (both p<0.001) associated with less efficient suppressive activity (p=0.012).

Conclusions

Skewed XCI plays a role in susceptibility to SSc, is not restricted and influences Foxp3 expression and the suppressive capacity of Tregs.

Copyright information

© Broen et al; licensee BioMed Central Ltd. 2010

This article is published under license to BioMed Central Ltd.

Authors and Affiliations

  • JCA Broen
    • 1
    • 4
  • ILM Wolvers-Tettero
    • 2
  • L Geurts-van Bon
    • 1
    • 4
  • M C Vonk
    • 1
  • MJH Coenen
    • 3
  • R Lafyatis
    • 4
  • TRDJ Radstake
    • 1
    • 4
  • A W Langerak
    • 2
  1. 1.Dept. of RheumatologyRadboud University Nijmegen Medical CentreNijmegenThe Netherlands
  2. 2.Dept. of ImmunologyErasmus MC, University Medical CenterRotterdamThe Netherlands
  3. 3.Dept. of Human GeneticsRadboud University Nijmegen Medical Centre NijmegenThe Netherlands
  4. 4.Dept. of RheumatologyBoston University School of MedicineBostonUSA

Personalised recommendations